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Summary
Purpose: To investigate neuronal dysfunction in the thalami of juvenile myoclonic
epilepsy (JME) by using proton magnetic resonance spectroscopy (MRS).
Methods: We performed single-voxel proton MRS over the right and the left thalami
of 15 consecutive patients (10 women, 5men) with JME (mean age 20.3 years) and 16
healthy volunteers (10 women, 6 men) (mean age 24.5 years). All patients had
seizure onset in late childhood—teenage, normal neurologic examination, typical
electroencephalogram (EEG) of JME and normal magnetic resonance imaging (MRI).
We determined N-acetylaspartate (NAA) values and NAA over creatine—phospho-
creatine (Cr) values. Mann—Whitney U-test was used to evaluate group differences.
Results: Group analysis showed that echo time (TE) 270 integral value of NAA
over left thalamus were significantly decreased in JME patients as compared
with controls (34.6033  15.8386; 48.0362  22.2407, respectively, P = 0.019). Also
group analysis showed that thalami NAA/Cr ratios were significantly decreased in
JME patients (right side, 2.21  1.07; left side 2.00  0.72) as compared with
controls (right side, 3.45  1.50; left side, 3.08  1.60; P = 0.011 and P = 0.030,
respectively).
Conclusion: In the previous studies, NAA values in patients with JME found that they
were not statistically lower in thalami than control group. But, in our study, NAA
value was found low as well. It has been known that NAA is a neuronal marker and
hence it is a valuable metabolite in the neuron physiopathology. As a result, in the
patients with JME we tried to support the theory that the underlying mechanism of
the generalized seizures was the abnormal thalamocortical circuity, determining
the thalamic neuronal dysfunction in MRS statistically.
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288 C. Haki et al.Introduction
Juvenile myoclonic epilepsy (JME) is a hereditary
epilepsy syndrome that comprises 5—11% of patients
with epilepsy.1 It is characterized bymyoclonic jerks
and generalized tonic-clonic seizures. The electro-
encephalogram (EEG) in JME typically shows gener-
alized 4—6 Hz spike andwave or poly-spike andwave
activity maximum in frontocentral regions. JME is
associated with normal intelligence and lack of
pathology on the MRI and computed tomography
(CT) scans.2,3
Recent neuropsychological studies, however sug-
gested that subjects with JME have a deficient
performance in several tests measuring frontal lobe
functions. Furthermore, in a PET study with 18-
fluorodeoxyglucose (18-F FDG), Swartz et al. found
inability to activate the dorsolateral prefrontal,
premotor and basal frontal cortex during visual
match to sample tasks.4 Unlike the control subjects,
patients with JME instead, activated the medial
temporal structures. These observations suggest
that JME may be associated with frontal lobe
abnormalities, perhaps affecting the epileptogenic
potential, as well as the cognitive functioning. Posi-
tron emission tomography (PET) studies suggest that
the benzodiazepine (BDZ) receptor density is
reduced in the thalamus and increased in the deep
cerebellar nuclei in generalized tonic-clonic epi-
lepsy5 and that frontal lobe binding to BDZ receptors
could be elevated in patients with JME.6 Proton
magnetic resonance spectroscopy (MRS) of the
human brain in vivo allows non-invasive quantifica-
tion of important biologic chemical compounds.
Proton magnetic spectra of the human brain in vivo
contains a large signal from N-acetyl groups that
originates largely from N-acetylaspartate (NAA), a
compound localized exclusively in neurons and
neuronal processes. The neuronal marker NAA is
reduced in certain diseases with neuronal loss or
dysfunction, including epilepsy.7,8
The exact mechanisms of generalized seizures
are still unclear. Nevertheless, evidence exists that
thalami participate in the generation of generalized
spike and wave discharges and absence seizures.9,10
Functional brain imaging has shown increased tha-
lamic blood flow during absence seizures.11The objective of the present study was to
investigate whether evidence exist of neuronal
dysfunction in the thalami in patients with JME
by using proton magnetic resonance spectroscopy
(MRS).Patients and methods
Fifteen patients observed with JME diagnosis were
included in this study. Their mean age was 20.3
(range, 16—30 years). The mean onset age of sei-
zures was 13.6 (range, 8—20 years). Five of those 15
patients were males and 10 were females. The
diagnosis of the patients was in accordance with
their EEG results, seizure semiology and medical
background. None of the patients had the other
kind of neurological and psychiatric diseases.
In all the patients seizures had started in late
childhood—teenage and their neurological examina-
tions were normal. There were typical 4—6 Hz spike
and poly-spike slow wave paroxysms in the EEG
recordings of all patients. Six of whom had general-
ized tonic-clonic, myoclonic and absence seizures,
seven of whom had generalized tonic-clonic and
myoclonic jerks, one of whom had myoclonic and
absence seizures and one of whom also had myo-
clonic seizures.
Thirteen patients have had valproic acid mono-
theraphy and two patients have had valproic acid
and lamotrigine treatment. Five patients had photo-
sensitivity. In all of them seizures had their onset in
late childhood or teenages. All patients had been
controlled for generalized tonic-clonic seizures for 1
year or longer before the MRS examinations. All had
been seizure-free for at least 24 h prior to the MRS
experiments. Also MRI results of whole patients
were normal.
This study was performed using circular polarized
head bandage at 1.5 Tesla supertransmitter magnet
(Magnetom Vision Plus, Siemens, Erlangen, Ger-
many). Our MRI protocol consisted of T1 weighted
axial, T1 weighted sagittal, T2 weighted axial, T1
weighted inversion recovery 3 mm thick images,
perpendicular to long axis of hippocampus and T2
weighted coronal fluid attenuated inversion recov-
ery (FLAIR) images were used.
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nuclei were normal. Both hippocampi, parahippo-
campal gyrus and amigdalas were observed normal.
There was not a view that could be in accordance
with mesial temporal sclerosis. Furthermore, both
thalami and frontal lobes have been observed to be
normal. In both thalamic areas volume of interest
(VOI) has been defined as 8 ml in the examination of
single voxel proton MR spectroscopy. VOI has been
performed to both thalami separately as a single
voxel proton MR spectroscopy (Fig. 1).
In the study point resolved surface coil spectro-
scopy (PRESS) was used. For the spectra, spin echo
(SE) sequence containing 135 and 270 ms echo time
was used. Time of repetition (TR) was obtained as
1500 ms and the mean signal to noise ratio 16 and
number of excitations (NEX) = 256 respectively. VOI
having been placed in a suitable area beforeFigure 1 In the right thalamus, it can be seen where the
sample with 8 ml dimension is.sequence, automatic shimming was performed using
3—7 Hz line width for the optimum signal of the
voxel. Localized shimming was repeated three or
four times, if necessary, to ensure good field homo-
geneity.
To suppress water, 908 gaussian pulse was per-
formed after the spoiler gradient. Before the Four-
ier inversion, 2048 time sequence data spots and
128 ms weak gaussian filters were selected to make
the eddy current correct. After the Fourier rever-
sing, linear basal line correction was made. After
the application of SE sequence which contains TE
270 and 135 ms echo time, using longer TE, T2
weighted spectrum had been obtained from both
thalami and the evaluation of creatine (Cr), N-acet-
ylene aspartate (NAA) was primarily made. These
are the crucial metabolites supporting information
neurochemically. After the spectrum was obtained,
post-processing procedure was performed. All data
acquired with long echo times were processed with
software provided by Siemens. Peak areas of meta-
bolites were quantified and then the position (the
place as parts per million (ppm)), integral (quantity
as millimol), width (the width of metabolites as ppm
at half pike length: 1/T2 time) and amplitude (as
maximum intensity) of the metabolites were held.
The ratio of NAA shows us the appearance of methyl
groups. Also, 2.0 ppm reaches to resonance. NAA is
accepted as neuronal marker and its concentration
becomes less in many diseases with brain damage. It
is not found outside the central nerve system and it
has the widest and highest pike in normal spec-
trum.12—16
Creatine (Cr) reaches to resonance at 3.03 ppm.
The second added pike is seen at 3.94 ppm. There-
fore, Cr pike is sometimes defined as the total Cr
pike. Creatine in ATP and ADP serves as reserve for
high-energy phosphate and also as a plug. It also
takes an important role in brain cells as an energy
dependent system.
While creatine increases in conditions where the
metabolism rate reduces, it reduces in instances
where metabolism increases. Much of the creatine
pike might be stable in diseases and it could be used
as the control value. Getting the integral and ampli-
tude values of NAA and NAA/Cr ratio in left and right
thalami which contains both 135 and 270 ms echo
time in SE sequence, it was comparatively evaluated
with a volunteered control group consisting of total
16 healthy people (6 males and 10 females). The
mean age of them was 24.5 (range, 16—35 years). It
was seen that 10% and 20% of MR spectroscopy voxel
had non-thalamic tissue inside. The measurement of
the 10—20% of non-thalamic tissue was done as this
way; VOI that has been defined as 8 ml in the
examination of single voxel proton MR spectroscopy
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was VOI of 1 ml volume. The non-thalamic tissue in
the 8 ml VOI varied between 1/8 and 1.5/8. That
was correspondence to 10—20% of non-thalamic
tissue in our VOI. Together with this, it was per-
ceived that this partial volume did not cause a
remarkable change in the evaluation of NAA signals.
Because, the non-thalamic tissue is formed from
axons, which have close relation with thalamic
nuclei.17
The measuring was evaluated by two different
radiologists (O.G.G. and A.U.G.). Spectral acquisi-
tion, quantification and analysis were performed by
one investigator (O.G.G.). Spectra with broad peaks
and poor separation of individual peaks were
excluded from study. The cause of this was basically
the movement of the patients. The normal and
patient groups whose spectras were that kind,
recalled again after few days later for new spectro-
scopy examination. Only spectra with restricted
peaks and good separation of individual peaks were
included in our study. Informed written consent
was obtained from each subject. Our study was
approved by the Ethic Committee of the Medical
Faculty.Results
There are many studies in which they explain that it
is a valid method to use the integral18,19 or the
amplitude20,21 values between patients and con-
trols. In our study, we use both integral and ampli-
tude values between patients and controls.Table 1 The distribution of MRS measuring of thalamic NA
Patient Integral value of NAA
R thalamus L thalamus
TE 135 TE 270 TE 135 TE 270
1 56.96 29.81 34.32 33.42
2 58.07 33.05 48.43 32.39
3 60.36 41.51 65.65 38.82
4 54.58 36.06 61.62 31.48
5 59.41 34.40 59.39 11.09
6 60.68 36.51 71.03 38.55
7 53.16 30.05 53.11 32.09
8 57.26 34.23 57.16 29.76
9 54.34 31.75 58.37 35.83
10 52.74 83.51 53.39 35.54
11 50.36 90.44 43.95 25.12
12 55.75 81.28 56.93 86.87
13 43.96 27.17 41.46 26.91
14 48.20 32.45 51.72 32.16
15 49.83 27.27 50.62 30.06
JME, juvenile myoclonic epilepsy; NAA, N-acetylaspartate; R, rightIn our study, Mann—Whitney U-test was used
statistically (P < 0.05 was accepted remarkable).
Age, gender, NAA and NAA/Cr ratios (as TE 135 and
270) between the patient group with JME and the
control group were compared. Age and gender
were unremarkable when the control group was
compared with the patient group (P > 0.05). The
values of NAA and NAA/Cr were presented in
Tables 1—4. When NAA in left thalamus was com-
pared with the control group, which was in the
value of TE 270 integral, it was determined as lower
in the patient group (P = 0.019, shown in Table 5).
In addition, in the left thalamus, TE 135 integral,
amplitude and TE 270 amplitude values were seen
as lower in the patient group when compared with
the control group. But, no statistically difference
was found (P > 0.05, presented in Table 5). Again,
in the right thalamus, though TE 270 amplitude
values were observed as lower in the patient group
in contrast to the control group they were not
found statistically significant (P > 0.05, shown in
Table 5).
NAA/Cr was found lower in the patient group
when TE 270 integral values in the right and left
thalami were compared with the control group
(right, P = 0.0011; left, P = 0.030; presented in
Table 6). In the right thalamus, TE 135 integral,
TE 270 amplitude values of NAA/Cr were found as
lower in the patient group in contrast to the control
group. But it was statistically unremarkable
(P > 0.05 shown in Table 6).
The spectroscopic images of a patient from both
the patient and control groups were comparatively
presented in Fig. 2.A values of patients with JME diagnosis
Amplitude value of NAA A
R thalamus L thalamus
TE 135 TE 270 TE 135 TE 270
22.12 18.06 31.38 18.09 22
28.09 15.24 17.22 19.51 22
27.83 18.85 21.33 16.61 17
22.07 12.38 22.45 12.90 26
30.23 10.15 25.40 5.11 19
25.95 13.64 27.23 14.97 27
23.07 15.56 25.28 15.41 25
23.47 11.48 19.85 9.55 23
23.94 14.87 25.33 14.90 26
25.52 17.98 22.19 13.99 21
22.52 11.82 17.07 11.51 22
25.71 13.00 24.35 17.84 25
22.93 11.46 13.90 9.93 20
22.94 14.08 25.44 13.96 16
23.34 11.50 28.73 15.57 30
; L, left; A, age (year); TE, time of echo.
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Table 2 The distribution of MRS measuring of thalamic NAA values of the control group
Normal Integral value of NAA Amplitude value of NAA A
R thalamus L thalamus R thalamus L thalamus
TE 135 TE 270 TE 135 TE 270 TE 135 TE 270 TE 135 TE 270
1 53.19 30.96 49.73 30.69 27.54 18.65 25.31 16.47 22
2 43.42 25.65 42.02 23.46 19.33 9.35 19.75 7.61 29
3 53.16 30.42 57.38 31.15 22.10 10.32 21.99 9.19 28
4 68.74 34.55 64.95 36.26 28.89 15.93 22.03 15.97 27
5 60.98 38.87 60.38 42.97 26.08 14.90 24.75 17.86 27
6 56.11 36.31 58.28 35.23 27.60 15.31 24.93 14.05 35
7 59.01 41.34 64.14 34.23 23.23 15.64 21.51 14.64 34
8 55.80 39.61 57.38 41.06 39.84 17.71 21.99 17.31 25
9 51.08 83.28 56.13 85.37 25.55 15.84 27.16 12.70 24
10 65.99 46.05 63.60 42.66 31.41 21.24 27.60 17.25 18
11 63.87 88.40 67.76 40.52 29.00 13.33 33.90 19.61 18
12 27.88 58.69 53.61 83.97 8.40 24.39 22.93 13.92 18
13 54.94 84.22 52.10 35.11 22.52 17.32 22.50 12.95 29
14 51.54 84.53 50.57 80.60 22.05 14.99 21.02 11.88 16
15 53.08 86.20 54.46 37.78 27.98 16.44 25.92 16.16 16
16 64.56 84.63 61.03 87.52 25.97 14.60 29.53 16.28 26
NAA, N-acetylaspartate; R, right; L, left; A, age (year); TE, time of echo.Discussion
The basic underlying mechanism of absence seizures
appears to involve thalamocortical circuity and the
generation of abnormal oscillatory rhythms from
particular neuronal networks.17,22—25 Both human
and animal data suggest that 3—4 Hz generalized
spike and wave discharges arise from abnormal
thalamocortical rhythms. EEG monitoring with
depth electrodes in the thalamic nuclei demon-
strated that thalamic epileptiform dischargesTable 3 The distribution of MRS measuring of thalamic NA
Patient Integral value of NAA/Cr
R thalamus L thalamus
TE 135 TE 270 TE 135 TE 270
1 1.931 1.951 1.811 1.758
2 2.007 1.631 2.031 1.931
3 2.007 1.931 2.541 1.791
4 1.481 1.981 2.911 1.281
5 1.731 1.641 2.231 2.251
6 1.761 1.701 2.841 2.651
7 2.031 1.671 1.541 2.041
8 1.751 1.591 2.341 1.641
9 1.897 1.607 2.056 1.730
10 1.996 4.624 2.132 1.734
11 2.400 4.747 1.820 1.371
12 1.806 3.082 1.959 4.352
13 1.379 1.301 2.270 1.819
14 1.550 1.855 1.796 1.871
15 2.157 2.228 1.780 1.840
JME, juvenile myoclonic epilepsy; NAA, N-acetylaspartate; Cr, creacorrelated with widespread surface cortical activ-
ities and clinical symptoms of absence seizures and
generalized tonic-clonic seizures.26
Experimental evidence that implicates thalamic
and thalamocortical mechanisms as important in the
pathophysiology of absence may offer an explana-
tion for the generalized nature of the ictus.27,28
However, the generalized nature of absence sei-
zures appears to be more a convention of interpre-
tation rather than a description of the EEG
evidence. Examination of EEG patterns in spikeA/Cr values of patients with JME diagnosis
Amplitude value of NAA/Cr A
R thalamus L thalamus
TE 135 TE 270 TE 135 TE 270
1.911 1.806 5.591 1.809 22
1.811 2.381 2.031 2.531 22
2.031 2.611 1.961 2.141 17
1.831 2.141 2.191 1.781 26
1.731 1.641 1.651 2.081 19
1.651 2.551 1.651 2.151 27
1.711 2.021 1.541 2.222 25
1.911 1.771 2.121 1.791 23
1.841 2.398 1.904 2.292 26
1.865 2.528 1.891 2.312 21
2.073 1.912 1.700 2.048 22
1.806 1.670 1.617 2.241 25
1.522 1.860 1.933 2.068 20
1.599 1.963 1.706 2.065 16
1.780 2.228 2.081 2.616 30
tine; R, right; L, left; A, age (year); TE, time of echo.
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Table 4 The distribution of MRS measuring of thalamic NAA/Cr values of the control group
Normal Integral value of NAA/Cr Amplitude value of NAA/Cr A
R thalamus L thalamus R thalamus L thalamus
TE 135 TE 270 TE 135 TE 270 TE 135 TE 270 TE 135 TE 270
1 2.022 1.854 1.742 1.712 1.811 2.612 1.742 2.211 22
2 1.592 5.632 1.772 1.845 1.921 2.175 1.833 2.021 29
3 2.171 3.475 2.401 5.701 1.921 1.865 2.024 2.011 28
4 2.741 3.512 8.402 3.115 2.111 2.201 2.774 2.574 27
5 2.042 1.756 1.562 2.333 1.961 2.142 2.082 2.396 27
6 1.751 1.695 2.524 2.011 1.531 1.895 1.783 2.236 35
7 3.134 3.902 2.875 1.475 2.462 3.705 2.092 2.135 34
8 2.077 1.802 1.975 1.895 1.793 2.456 1.842 2.545 25
9 1.903 5.175 1.932 6.190 1.806 2.534 1.552 2.653 24
10 1.879 1.846 1.845 2.040 2.000 2.365 1.763 2.208 18
11 1.894 5.000 2.685 2.610 2.039 2.454 2.276 2.523 18
12 1.497 2.282 1.825 5.110 1.527 1.832 1.958 2.237 18
13 2.451 3.280 1.765 1.633 1.838 2.258 1.576 2.042 29
14 1.910 3.942 1.565 4.298 1.717 2.368 1.895 2.148 16
15 1.738 6.237 2.038 2.407 1.955 2.660 1.972 2.830 16
16 2.047 3.936 2.000 4.984 2.010 2.302 2.000 2.292 26
NAA, N-acetylaspartate; Cr, creatine; R, right; L, left; A, age (year); TE, time of echo.and wave discharges shows that, although they
develop rapidly and may be difficult to lateralize,
the spike and wave patterns are not diffuse but are
predominant over the frontal cortex.29,30 This fron-
tal distribution of both spikes and waves is clear in
textbook examples of conventional EEG in absence
seizures, even those that are described as having
generalized onset.30 Other investigators pointed out
that epileptiform discharges in some patients with
childhood absence may appear fragmentary, espe-
cially during sleep, and produce focal spikes over
centrotemporal and occipital regions.31 This evi-
dence of spike and wave seizures associated with
activity in mesial frontal cortex during sleep onset
may be congruent with the importance of corti-
cothalamic circuity in both spike and wave dis-
charges and in sleep spindles in animal models.32Table 5 The distribution of MRS measure of thalamic NAA
controls
NAA Patients: 15
(mean  standard deviation)
R 135 amplitude 24.7340  2.5509
L 135 amplitude 23.0580  4.632
R 135 integral 55.0673  62649
L 135 integral 53.1200  8.4002
R 270 amplitude 14.0933  2.7209
L 270 amplitude 13.9013  3.7484
R 270 integral 60.8353  67.1985
L 270 integral 34.6033  15.8386
JME, juvenile myoclonic epilepsy; NAA, N-acetylaspartate; R, right
a It is statistically significant according to Mann—Whitney U-test
observed that in integral value, there was statistically difference iWith the advances in physical models of the neural
sources of EEG activity in recent decades, it has
become possible to relate the frontal distribution of
spike and wave patterns to electrical sources in
specific regions of frontal cortex. Applying equiva-
lent dipole analysis to generalized spike and wave
complexes with the spatiotemporal model has sug-
gested that the most common model includes a
source in the midline region of the basal frontal
lobe.33 In further research, current source density
analysis was applied to spike and wave patterns in
conventional EEG recordings in five children with
absence seizures.34 These analyses again empha-
sized the importance of inferior frontal generators,
with spikes often showing a focal current distribu-
tion over frontopolar and orbital frontal cortex.34
This evidence of a specific frontal cortical focus forvalues of the patients with the JME diagnosis and their
Controls: 16
(mean  standard deviation)
P-Value
24.2181  5.4630 >0.05
25.4899  4.9634 >0.05
53.3344  11.7065 >0.05
57.0950  6.6547 >0.05
15.9850  3.6303 >0.05
14.9281  3.2417 >0.05
55.8569  24.5888 >0.05
48.0362  22.2407 0.019a
; L, left; TE, time of echo.
. In the left thalamus when TE 270 was obtained, it has been
n patient group according to normal control group (P = 0.019).
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Table 6 The distribution of MRS measure of thalamic NAA/Cr values of the patients with the JME diagnosis and their
controls
NAA/Cr Patients: 15
(mean  standard deviation)
Controls: 16
(mean  standard deviation)
P-Value
R 135 amplitude 1.8049  0.1493 1.9001  0.2236 >0.05
L 135 amplitude 2.1046  0.9854 1.9477  0.2902 >0.05
R 135 integral 1.8590  0.2658 2.0530  0.4184 >0.05
L 135 integral 2.1575  0.3827 2.4317  1.6388 >0.05
R 270 amplitude 2.0988  0.3318 2.3640  0.4375 >0.05
L 270 amplitude 2.1432  0.2437 2.3163  0.2446 >0.05
R 270 integral 2.2175  1.0756 3.4579  1.5005 0.011a
L 270 integral 2.0041  0.7264 3.0849  1.6062 0.030a
JME, juvenile myoclonic epilepsy; NAA, N-acetylaspartate; Cr, creatine; R, right; L, left; TE, time of echo.
a It is statistically significant according to Mann—WhitneyU-test. In the left and right thalami when TE 270 was obtained, it has been
observed that in integral value, there was statistically difference in patient group according to normal control group (R, P = 0.011; L,
P = 0.030).generalized seizures may seem at variance with the
evidence that thalamocortical mechanisms are
responsible for widespread seizure discharges. How-
ever, neurophysiological analyses of thalamocorti-
cal augmenting and recruiting responses in animal
experiments in the 1940s showed that cortical net-
works, specifically including orbital frontal cortex,
were important in regulating the thalamocortical
circuity.35,36 With the modern recognition that this
circuity is mediated by the nucleus reticularis tha-
lami (RE), the cortical modulation of thalamocorti-
cal controls by orbital frontal regions has been an
important explanatory principle.37,38 The necessity
of cortical involvement is clear in the corticothala-
mic circuity of sleep spindles, also mediated by RE
mechanisms and taken as abnormal model for the
circuity that becomes pathological in spike andFigure 2 At 2.0 ppm NAA integral values in a sample of the
group and amale of the patient groupwith JME could be seen. P
lower in the patient with JME. Furthermore, pike of lipid-la
followed. (a) Control group and (b) patient group.wave complexes.39,40 Furthermore, in an animal
model of absence using intracranial EEG recordings,
a cortical focus has been shown to drive spike and
wave thalamocortical discharges, implying that the
fundamental pathophysiologymay, in fact, originate
cortically.41 A previous work showed no change in
the NAA/Cr values in temporal lobes of five adult
patients with JME.8 One patient had a MRS exam-
ination <4 h after absence status and four others
also had MRS examinations during the interictal
state (seizure free for >24 h).8
Another study using short TE stimulated echo
acquisition (STEAM) proton MRS found that absolute
NAA values were significantly lower in the frontal
lobes of patients with JME as compared with con-
trols, but found no significant differences in NAA
values from right thalamus on group analysis. Threeright thalamus taken from a female of the normal control
lease pay attention to NAA integral value, whichwasmuch
ctate in the patient with JME (0.7—1.33 ppm) could be
294 C. Haki et al.of their patients had abnormally low absolute NAA
values in the frontal lobes. However, NAA/Cr ratios
and NAA/Cho ratios did not differ between patients
and controls in thalami, frontal lobes and occipital
lobes.18 Discrepancies between those findings18 and
our study could be explained by differences
in acquisition and postprocessing techniques. The
VOI selection with STEAM yields a volume larger than
the one selected with PRESS under the same experi-
mental conditions.42,43 Sequence design considera-
tions, especially with regard to placement of the
spoiler and refocusing gradients, make STEAM more
sensitive to diffusion than PRESS.42,43 Furthermore,
when only variations in the major metabolite peaks
(NAA, Cho, Cr, lactate) are considered7 long TE
PRESS sequences, as in our study, offer the benefit
of more simplified spectra with reduced contribu-
tion from lipid signals and more rectilinear baseline,
which facilitate interpretation and quantitation of
peak areas.
Moreover, as well as STEAM sequence is known to
be more sensitive to movement; PRESS sequence is
known to be less sensitive to movement and the
signal to noise (SNR) ratio is much more. It is
declared that with the application of MR spectro-
scopy in the same time with cardiac movements
metabolite pikes become much clearer in brain
and it reduces artefacts.44—46 In a previous study
Li et al. studied patients with localization-related
epilepsy. Patients were divided into three groups
according to the EEG investigation: temporal lobe
epilepsy, extratemporal lobe epilepsy and multilo-
bar epilepsy. They found NAA/Cr reduction was
more often widespread in the multilobar group than
in temporal or extratemporal groups.47 In another
study (Bernasconi et al.48) they showed that there
was an abnormally low concentration of thalamic
NAA/Cr in idiopathic generalized epilepsy (IGE)
patients compared with healthy controls, but there
was no difference in the concentration of NAA/Cr in
the insular cortex, posterior temporal lobe, white
matter and splenium of the corpus callosum. Also
there was no difference in NAA/Cr between patients
whose seizures were well controlled and those in
whom seizures were not controlled. They found a
significant negative correlation between thalamic
NAA/Cr and duration of epilepsy.48 In the study of
Savic and co-workers, JME patients showed signifi-
cantly lower concentrations of frontal lobe NAA than
controls, as well as patients with generalized tonic
clonic epilepsy (GTCS). In contrast the frontal lobe
values in patients with GTCS were not different from
normal. Patients with GTCS, on the other hand had
significantly reduced concentration of NAA in tha-
lamus compared with controls. Also they found the
corresponding value in patients with JME was alsolower, but the difference did not reach the level of
significance.19
In the study of Mory et al.17 in both thalami
related with PRESS sequence (TE 135) on 10 patients
with JME; they found NAA/Cr ratio lower in contrast
to the control group.17 Also, our study was per-
formed with the PRESS sequence and TE 135 and
270 were taken from both thalami. Although there is
statistically a significant difference for TE 270 inte-
gral NAA/Cr value in both right and left thalami
(right, P = 0.011; left, P = 0.030) there is statisti-
cally observed a crucial difference for TE 270 inte-
gral NAA value in the left thalamus (P = 0.019).
In the studies before, it was seen that in thalamus
NAA values for the patients with JME were not
statistically lower than the control group. But,
NAA value was found lower in our study. It is evident
that NAA is a neuronal marker and so it is a very
crucial metabolite for neuron physiopathology.
In conclusion, these preliminary findings of abnor-
mal NAA/Cr ratios and left thalamic NAA value in
patientwith JME support thehypothesis of a thalamic
dysfunction as part of the underlying mechanisms of
epileptogenesis (abnormal thalamocortical circuity)
in this form of generalized epilepsy.References
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